SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $36,907,000 | -21.1% | 242,889 | -38.1% | 0.98% | -17.3% |
| Q1 2019 | $46,751,000 | +72.3% | 392,243 | +57.7% | 1.19% | +54.9% |
| Q4 2018 | $27,140,000 | +137.5% | 248,691 | +251.5% | 0.77% | +237.3% |
| Q3 2018 | $11,429,000 | +222.9% | 70,761 | +164.3% | 0.23% | +212.3% |
| Q2 2018 | $3,539,000 | -35.1% | 26,772 | -78.0% | 0.07% | -21.5% |
| Q3 2017 | $5,457,000 | +234.8% | 121,758 | +151.8% | 0.09% | +244.4% |
| Q2 2017 | $1,630,000 | +61.9% | 48,363 | +42.1% | 0.03% | +92.9% |
| Q1 2017 | $1,007,000 | +197.1% | 34,027 | +175.0% | 0.01% | +250.0% |
| Q4 2016 | $339,000 | – | 12,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |